FABP4 and colorectal cancer: Using enzyme-linked immunosorbent assay, Ru et al. (2019) detected that the level of FABP4 is significantly higher in patients’ serum than that before surgery, and they suggested that FABP4 expression is related to the pathogenesis of colorectal cancer.